News

Sarepta Refused FDA’s Request to Halt Elevidys Shipments
A third patient has died this year after getting a gene therapy from Sarepta Therapeutics Inc., raising questions about the ...
Fierce Biotech8d
UPDATED: Analysts demand transparency after Sarepta's roundabout disclosure of 3rd patient death
On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.
Devdiscourse8d
FDA Scrutiny Intensifies as Sarepta Gene Therapy Faces Dire Setbacks
The FDA is set to request Sarepta Therapeutics to halt shipments of its gene therapy, Elevidys, after a third patient's death ...
FDA asks Sarepta to stop shipping gene therapy after patient deaths. Sarepta says no.
The FDA says it has asked Sarepta Therapeutics to voluntarily stop all shipments of Elevidys after the company confirmed a third patient death related to one of its gene therapies.